Vidal-Puig AJ - Search Results

1

Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.

Sethi JK, Vidal-Puig AJ. Sethi JK, et al. J Lipid Res. 2007 Jun;48(6):1253-62. doi: 10.1194/jlr.R700005-JLR200. Epub 2007 Mar 20. J Lipid Res. 2007. PMID: 17374880 Free PMC article. Review.

2

Obesity and diabetes: an avalanche of new information.

Vidal-Puig A, O'Rahilly S. Vidal-Puig A, et al. Mol Med Today. 2000 Jun;6(6):221-3. doi: 10.1016/s1357-4310(00)01714-7. Mol Med Today. 2000. PMID: 10939842 No abstract available.

3

Mitochondrial uncoupling proteins (UCPs) and obesity.

Crowley V, Vidal-Puig AJ. Crowley V, et al. Nutr Metab Cardiovasc Dis. 2001 Feb;11(1):70-5. Nutr Metab Cardiovasc Dis. 2001. PMID: 11383327 Review.

4

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Savage DB, et al. Diabetes. 2001 Oct;50(10):2199-202. doi: 10.2337/diabetes.50.10.2199. Diabetes. 2001. PMID: 11574398

5

Resistin: a new link between obesity and insulin resistance?

Vidal-Puig A, O'Rahilly S. Vidal-Puig A, et al. Clin Endocrinol (Oxf). 2001 Oct;55(4):437-8. doi: 10.1046/j.1365-2265.2001.01377.x. Clin Endocrinol (Oxf). 2001. PMID: 11678824 Review. No abstract available.

6

Lamin expression in human adipose cells in relation to anatomical site and differentiation state.

Lelliott CJ, Logie L, Sewter CP, Berger D, Jani P, Blows F, O'Rahilly S, Vidal-Puig A. Lelliott CJ, et al. J Clin Endocrinol Metab. 2002 Feb;87(2):728-34. doi: 10.1210/jcem.87.2.8256. J Clin Endocrinol Metab. 2002. PMID: 11836312

7

Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha.

Sewter C, Berger D, Considine RV, Medina G, Rochford J, Ciaraldi T, Henry R, Dohm L, Flier JS, O'Rahilly S, Vidal-Puig AJ. Sewter C, et al. Diabetes. 2002 Apr;51(4):1035-41. doi: 10.2337/diabetes.51.4.1035. Diabetes. 2002. PMID: 11916923

8

PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?

Sewter C, Vidal-Puig A. Sewter C, et al. Diabetes Obes Metab. 2002 Jul;4(4):239-48. doi: 10.1046/j.1463-1326.2002.00187.x. Diabetes Obes Metab. 2002. PMID: 12099972 Review. No abstract available.

9

Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes.

Sewter C, Blows F, Considine R, Vidal-Puig A, O'Rahilly S. Sewter C, et al. J Clin Endocrinol Metab. 2002 Sep;87(9):4203-7. doi: 10.1210/jc.2002-011511. J Clin Endocrinol Metab. 2002. PMID: 12213872

10

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.

Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpleby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O'Rahilly S. Savage DB, et al. Diabetes. 2003 Apr;52(4):910-7. doi: 10.2337/diabetes.52.4.910. Diabetes. 2003. PMID: 12663460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results